Mabvax Therapeutics
Latest round
- Series B
Last raised
- Nov 2012
Total raised
- $13M
Investors
- 4
About Mabvax Therapeutics
Mabvax Therapeutics, Inc. is a biotechnology company focused on developing innovative antibody-based therapies for the treatment of cancer.Mabvax Therapeutics, Inc. operates as a biotechnology firm specializing in antibody-based cancer therapies. Founded in 2006 and headquartered in San Diego, US, the company underwent a strategic merger with Telik in May 2014, resulting in its public listing. CEO David Hansen leads the organization, continuing the commitment to therapeutic innovation.Mabvax Therapeutics is dedicated to developing targeted antibody-based therapies that specifically address cancer treatment. Their innovative product pipeline includes therapeutic candidates designed to enhance the efficacy of existing treatments and improve patient outcomes.In the most recent year, 2017, Mabvax Therapeutics reported zero revenue, with an EBITDA loss of USD 17,516,791.Mabvax Therapeutics aims to expand its product offerings by advancing new antibody therapies currently in development. The company is targeting further growth in key markets, particularly in North America and Europe, by 2025.61 mn will be utilized to support the development of these new therapies and facilitate the company's expansion into additional markets. The merger in 2014 with Telik positioned Mabvax for broader market engagement, enhancing its capabilities and reach.
Who invested in Mabvax Therapeutics
4 investors across 2 rounds
See all investors in Mabvax Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mabvax Therapeutics
Who invested in Mabvax Therapeutics?
Mabvax Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mabvax Therapeutics raised?
Mabvax Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mabvax Therapeutics last raise money?
Mabvax Therapeutics's most recent round on record is a Series B, in Nov 2012.
What does Mabvax Therapeutics do?
Mabvax Therapeutics is a pharmaceuticals company.
Where is Mabvax Therapeutics headquartered?
Mabvax Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Mabvax Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Mabvax Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Mabvax Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.